Literature DB >> 1554374

Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors.

K Kashfi1, G A Cook.   

Abstract

Proteolysis of intact mitochondria by Nagarse (subtilisin BPN') and papain resulted in limited loss of activity of the outer-membrane carnitine palmitoyltransferase, but much greater loss of sensitivity to inhibition by malonyl-CoA. In contrast with a previous report [Murthy & Pande (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 378-382], we found that trypsin had no effect on malonyl-CoA sensitivity. Even when 80% of activity was destroyed by trypsin, there was no difference in the malonyl-CoA sensitivity of the enzyme remaining. Trypsin caused release of the intermembrane-space enzyme adenylate kinase, indicating loss of integrity of the mitochondrial outer membrane, whereas Nagarse and papain caused no release of that enzyme. Citrate synthase was not released by any of the three proteinases, indicating no damage to the mitochondrial inner membrane. When we examined the effects of proteolysis on the inhibition of carnitine palmitoyltransferase by a wide variety of inhibitors having different mechanisms of inhibition, we found differential proteolytic effects that were specific for those inhibitors (malonyl-CoA and hydroxyphenylglyoxylate) that have their inhibitory potencies diminished by changes in physiological state. Both of those inhibitors protected carnitine palmitoyltransferase from the effects of proteolysis, but did not inhibit the proteinases directly. Inhibition by two other inhibitors (DL-2-bromopalmitoyl-CoA and N-benzyladriamycin 14-valerate) was not altered by proteinase treatment, even when most of the enzyme activity had been destroyed. Inhibition by glyburide, which is minimally affected by physiological state, was affected only to a slight extent at the highest concentration of trypsin tested. Proteolysis by Nagarse appeared to produce loss of co-operativity in malonyl-CoA inhibition. The effects of proteolysis are discussed and compared with changes in Ki occurring with changing physiological states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554374      PMCID: PMC1130873          DOI: 10.1042/bj2820909

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Activation of a D-form of rabbit muscle glycogen synthase by Ca2+-activated protease.

Authors:  A Hiraga; S Tsuiki
Journal:  FEBS Lett       Date:  1986-09-01       Impact factor: 4.124

2.  Characterization of hepatic carnitine palmitoyltransferase. Use of bromoacyl derivatives and antibodies.

Authors:  P S Brady; A K Dunker; L J Brady
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

3.  Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues.

Authors:  K Kashfi; M Israel; T W Sweatman; R Seshadri; G A Cook
Journal:  Biochem Pharmacol       Date:  1990-10-01       Impact factor: 5.858

4.  Differences in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA are due to differences in Ki values.

Authors:  G A Cook
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

5.  Phosphorylation of native 97-kDa 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver. Impact on activity and degradation of the enzyme.

Authors:  R A Parker; S J Miller; D M Gibson
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

6.  Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria.

Authors:  T C Kiorpes; D Hoerr; W Ho; L E Weaner; M G Inman; G F Tutwiler
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

7.  Conditions for the self-catalysed inactivation of carnitine acetyltransferase. A novel form of enzyme inhibition.

Authors:  J F Chase; P K Tubbs
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

8.  Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes.

Authors:  M S Murthy; S V Pande
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

9.  Binding of [14C]malonyl-CoA to rat liver mitochondria after blocking of the active site of carnitine palmitoyltransferase I. Displacement of low-affinity binding by palmitoyl-CoA.

Authors:  B D Grantham; V A Zammit
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

10.  Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.

Authors:  J F Chase; P K Tubbs
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

View more
  10 in total

1.  Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane.

Authors:  F Fraser; C G Corstorphine; V A Zammit
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 2.  Mitochondrial Metabolism in Aging Heart.

Authors:  Edward J Lesnefsky; Qun Chen; Charles L Hoppel
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

Review 3.  Differential regulation in the heart of mitochondrial carnitine palmitoyltransferase-I muscle and liver isoforms.

Authors:  E A Park; G A Cook
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

4.  Regulation of carnitine palmitoyltransferase I (CPT-Ialpha) gene expression by the peroxisome proliferator activated receptor gamma coactivator (PGC-1) isoforms.

Authors:  Prabodh Sadana; Yi Zhang; Shulan Song; George A Cook; Marshall B Elam; Edwards A Park
Journal:  Mol Cell Endocrinol       Date:  2006-12-16       Impact factor: 4.102

5.  Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insights from expression of chimaeric proteins and mutation of conserved histidine residues.

Authors:  S T Swanson; D W Foster; J D McGarry; N F Brown
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

6.  Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids.

Authors:  R L Mynatt; J J Greenhaw; G A Cook
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

7.  Activity of carnitine palmitoyltransferase in mitochondrial outer membranes and peroxisomes in digitonin-permeabilized hepatocytes. Selective modulation of mitochondrial enzyme activity by okadaic acid.

Authors:  M Guzmán; M J Geelen
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

8.  Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency.

Authors:  S Zierz
Journal:  Clin Investig       Date:  1994-12

9.  Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I.

Authors:  E A Park; R L Mynatt; G A Cook; K Kashfi
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

10.  Diabetes and proteolysis: effects on carnitine palmitoyltransferase-I and malonyl-CoA binding.

Authors:  K Kashfi; L Cagen; G A Cook
Journal:  Lipids       Date:  1995-05       Impact factor: 1.880

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.